In The News Posted November 13, 2021 Share Posted November 13, 2021 SAN DIEGO, Nov. 13, 2021 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of: (1) Silverback Therapeutics Inc. (NASDAQ: SBTX) common stock pursuant and/or traceable to the offering documents issued in connection with Silverback Therapeutics' initial...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts